Israel adult stem cell trials – hope for ALS patients?

TEL AVIV (Reuters) - A clinical trial of ALS patients conducted by BrainStorm Cell Therapeutics shows its adult stem cell therapy is well-tolerated, appears to be safe and does not present undue risk, according to an interim safety review. Moreover, in some patients signs of stabilization of the disease were detected. Israel-based BrainStorm is developing NurOwn for the treatment of amyotrophic ...

Original post:

Israel adult stem cell trials - hope for ALS patients?

Related Posts

Comments are closed.